MetLife Investment Management’s ADMA Biologics ADMA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.7M	Buy	1,738,062 +356,474	+26%	+$5.63M	0.08%	241
2025 Q4	$25.2M	Buy	1,381,588 +71,554	+5%	+$1.21M	0.12%	115
2025 Q3	$19.2M	Buy	+1,310,034	New	+$22.5M	0.09%	176
2025 Q2	–	Sell	-1,108,911	Closed	-$22M	–	2742
2025 Q1	$22M	Buy	1,108,911 +972,699	+714%	+$16.8M	0.12%	132
2024 Q4	$2.34M	Buy	136,212 +6,060	+5%	+$114K	0.01%	961
2024 Q3	$2.6M	Hold	130,152	–	–	0.01%	888
2024 Q2	$1.46M	Buy	130,152 +21,693	+20%	+$182K	0.01%	1141
2024 Q1	$716K	Sell	108,459 -2,007	-2%	-$11K	﹤0.01%	1487
2023 Q4	$499K	Hold	110,466	–	–	﹤0.01%	1683
2023 Q3	$395K	Hold	110,466	–	–	﹤0.01%	1775
2023 Q2	$408K	Hold	110,466	–	–	﹤0.01%	1840
2023 Q1	$366K	Buy	110,466 +23,110	+26%	+$79.9K	﹤0.01%	1847
2022 Q4	$339K	Sell	87,356 -10,902	-11%	-$33.6K	﹤0.01%	1886
2022 Q3	$239K	Hold	98,258	–	–	﹤0.01%	2168
2022 Q2	$195K	Buy	+98,258	New	+$193K	﹤0.01%	2341
2020 Q2	–	Sell	-36,875	Closed	-$106K	–	2298
2020 Q1	$106K	Buy	+36,875	New	+$127K	﹤0.01%	2040
2019 Q4	–	Sell	-26,341	Closed	-$117K	–	2301
2019 Q3	$117K	Buy	+26,341	New	+$110K	﹤0.01%	2244